We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 05 APRIL 2016
Sequenom Asks The Supreme Court To Clarify The Limits On Section 101

BakerHostetler
Contributor

BakerHostetler
Recognized as an innovator and one of the top firms for client service, BakerHostetler helps...
View firm profileOn March 21, 2016, Sequenom filed a writ of certiorari with the U.S. Supreme Court, asking the Court to provide clarification regarding the limits of 35 U.S.C §101 as it relates to patent eligibility of diagnostic tests.
United StatesIntellectual Property










